BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
14.95
-0.46 (-2.99%)
Jan 7, 2026, 2:07 PM EST - Market open
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $536.03 million as of January 7, 2026. Its market cap has increased by 247.74% in one year.
Market Cap
536.03M
Enterprise Value
263.80M
1-Year Change
247.74%
Ranking
Category
Stock Price
$14.95
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has decreased from $615.01M to $536.03M, a decrease of -12.84%. That is a compound annual growth rate of -10.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 552.53M | 16.48% |
| Dec 31, 2025 | 474.36M | 128.54% |
| Dec 31, 2024 | 207.56M | -66.25% |
| Sep 26, 2024 | 615.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |